| Specifications | |
|---|---|
| Product type | mRNA |
| Modified bases | Pseudo-UTP |
| 5' Cap | Cap 1 |
| Species | Human |
| RefSeq | NM_013339.4 |
| Applications | Gene therapy research |
| Format | Powder |
| Quantity | 100 µg |
| Purification | Chromatography |
| Target Gene | |
|---|---|
| Gene ID | 29929 |
| UniProt ID | Q9Y672 |
| Specifications | |
|---|---|
| Product type | mRNA |
| Modified bases | Pseudo-UTP |
| 5' Cap | Cap 1 |
| Species | Human |
| RefSeq | NM_013339.4 |
| Applications | Gene therapy research |
| Format | Powder |
| Quantity | 100 µg |
| Purification | Chromatography |
| Target Gene | |
|---|---|
| Gene ID | 29929 |
| UniProt ID | Q9Y672 |
| Download |
|---|
| Download resources about mRNA therapeutics development to boost your research. |
| CUSTOMER REVIEWS and Q&As | |
|---|---|
|
There are currently no Customer reviews or questions for IVTScrip™ mRNA-Human ALG6, (Cap 1, Pseudo-UTP, 30 nt-poly(A)) (GTTS-WK19917MR). Click the button above to contact us or submit your feedback about this product. |
|
| See other products | |||
|---|---|---|---|
| CAT | Product Name | Product Type | CDs |
| GTTS-WK16581MR | IVTScrip™ mRNA-Human AKT2, (Cap 0, N1-Methylpseudo-UTP, 30 nt-poly(A)) | mRNA | AKT2 |
| GTTS-WK0973MR | IVTScrip™ mRNA-Human CD309, (Cap 0, 2-Thio-UTP, 120 nt-poly(A)) | mRNA | CD309 |
| GTTS-WK26356MR | IVTScrip™ mRNA-Human ATG16L2, (Cap 1, 2-Thio-UTP, 120 nt-poly(A)) | mRNA | ATG16L2 |
| GTTS-WK7619MR | IVTScrip™ mRNA-Human ACCSL, (Cap 0, N1-Methylpseudo-UTP, 120 nt-poly(A)) | mRNA | ACCSL |
| GTTS-WK13056MR | IVTScrip™ mRNA-Human ACSS3, (Cap 1, N1-Methylpseudo-UTP, 30 nt-poly(A)) | mRNA | ACSS3 |
| GTTS-WK7383MR | IVTScrip™ mRNA-Human ACYP2, (Cap 0, Pseudo-UTP, 120 nt-poly(A)) | mRNA | ACYP2 |
| GTTS-WK18304MR | IVTScrip™ mRNA-Human AGMO, (Cap 1, N1-Methylpseudo-UTP, 120 nt-poly(A)) | mRNA | AGMO |
| GTTS-WK11545MR | IVTScrip™ mRNA-Human ACSF3, (Cap 1, 5-Methoxy-UTP, 120 nt-poly(A)) | mRNA | ACSF3 |